Results 201 to 210 of about 13,720 (213)

The IL-33/ST2 pathway: therapeutic target and novel biomarker

Nature Reviews Drug Discovery, 2008
Rahul Kakkar, Richard T Lee
exaly  

Magnitude of Soluble ST2 as a Novel Biomarker for Acute Aortic Dissection

Circulation, 2018
Yuan Wang, Xin Tan, Hai Gao
exaly  

Identification of Serum Soluble ST2 Receptor as a Novel Heart Failure Biomarker

Circulation, 2003
Shin-Ichi Tominaga, Richard T Lee
exaly  

Soluble ST2 protein inhibits LPS stimulation on monocyte-derived dendritic cells

Cellular and Molecular Immunology, 2012
Shin-Ichi Tominaga, Ken Yanagisawa, Satoshi Ohta   +2 more
exaly  

Prognostic Value of Soluble ST2 After Myocardial Infarction: A Community Perspective

American Journal of Medicine, 2017
Allan S Jaffe, Omar F Abouezzeddine, Maurice Enriquez-Sarano   +2 more
exaly  

GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD

American Journal of Kidney Diseases, 2018
Ronit Katz, Zeenat Yousuf Bhat, Ian H De Boer   +2 more
exaly  

Soluble ST2 for Predicting Sudden Cardiac Death in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction

Journal of the American College of Cardiology, 2009
Jordi Ordonez-Llanos, Juan Cinca, Antoni Bayés-Genís   +2 more
exaly  

Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus

Rheumatology, 2010
M Y Mok, Damo Xu
exaly  

Up-Regulation of Interleukin 33 and Soluble ST2 Serum Levels in Liver Failure

Journal of Surgical Research, 2010
Matthias Zimmermann, Peter Faybik, Stefan Hacker   +2 more
exaly  

Mast cells control lung type 2 inflammation via prostaglandin E2-driven soluble ST2

Immunity
Tahereh Derakhshan, Barbara Balestrieri, Daniel F Dwyer   +2 more
exaly